Table 1. Sensitivity of viral variants to receptor antagonists.
Viral variant | |||||||
Target cell | B14 | B19 | B28 | B30 | B31 | B32 | |
anti- CD1341 | MYA-1 | 0.11 | 0.34 | 0.16 | 0.26 | >50 | >50 |
sFc- CD134 | MYA-1 | 25 | 1.1 | 18 | 1.6 | 1.4 | 0.7 |
MCC- CD134 | 40 | 1.8 | 20 | 1.5 | 1.6 | 1.3 | |
AMD3100 | MYA-1 | 0.0045 | 0.06 | 0.03 | 0.02 | 0.035 | 0.025 |
CLL- CD134 | 0.14 | 0.4 | 1.0 | 0.5 | 0.5 | 0.5 |
Inhibitory concentration 50% (IC50) in µg/ml.